New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2012
10:03 EDTALJ, ALDW, GALE, WHF, TSONOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Alon USA Energy (ALJ) initiated with a Buy at Goldman... Alon USA Partners (ALDW) initiated with a Neutral at Goldman... Galena Biopharma (GALE) initiated with an Overweight at Piper Jaffray... WhiteHorse Finance (WHF) initiated with an Outperform at RW Baird... TranS1 (TSON) initiated with an Outperform at Barrington... WhiteHorse Finance (WHF) initiated with a Buy at Stifel Nicolaus
News For ALJ;ALDW;GALE;WHF;TSON From The Last 14 Days
Check below for free stories on ALJ;ALDW;GALE;WHF;TSON the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
13:47 EDTWHFWhiteHorse Finance names William Market as COO
WhiteHorse Finance announced that William Markert has joined the company as COO, effective August 1. Ethan Underwood, the company’s current COO, will continue his role as managing director of H.I.G. WhiteHorse Advisers, LLC, the company’s investment adviser. William Markert most recently served as CFO of Securus Technologies, an integrated communications and technology provider.
July 22, 2014
15:46 EDTGALEGalena in-license of Zuplenz makes sense, says Piper Jaffray
Subscribe for More Information
09:55 EDTGALEGalena 'stands little chance' of improving Zuplenz sales, TheStreet says
After Galena BioPharma entered into a license agreement with MonoSol Rx for Zuplenz, TheStreet's Adam Feuerstein predicted that the company "stands little chance of delivering higher sales of Zuplenz than its previous marketer," calling the drug one that "no one wants" and "something to promote while waiting for the phase III study of NeuVax in breast cancer to inevitably fail." Reference Link
07:21 EDTGALEGalena enters into licensing agreement with MonoSol Rx
MonoSol Rx announced that it has licensed Zuplenz to Galena Biopharma. Zuplenz is an oral soluble film, or OSF, for the prevention of chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting. The licensing agreement includes an undisclosed upfront payment from Galena, as well as double digit royalty payments from sales of Zuplenz. Zuplenz is the first oral soluble lingual film product approved by the FDA as a prescription medication, based on MonoSol Rx's proprietary PharmFilm technology.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use